Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Cohort study on obesity, diabetes, and inflammation across different ethnicities

Official title: Development of a Multi-Ethnic, Multimodal Obesity Cohort

Run by University of California, San Francisco · NCT03022682 · Data updated 2026-11-12

This study is trying to understand how obesity, diabetes, and inflammation are connected across different ethnic groups by gathering health information and samples from 350 adults with stable weight.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment350 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (San Francisco, California)
StatusRecruiting
StartedFebruary 2015
Main results expectedDecember 2029
Study endsDecember 2029
Registry record updatedSeptember 8, 2026
Trial IDNCT03022682 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy individuals aged 18-75, with or without diabetes, who have a stable weight and may include those undergoing bariatric surgery.

Probably not a fit

Patients with chronic kidney disease, autoimmune diseases, or those with significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to recruit 350 participants aged 18-75 from various ethnic backgrounds to investigate the relationship between obesity, diabetes, and inflammation. Participants will provide data and biological samples, including blood, stool, and adipose tissue, to better understand the impact of ethnicity and body mass index on diabetes risk. The study focuses on individuals with stable weight, including those scheduled for bariatric or abdominal surgery, to gather comprehensive insights into these interconnected health issues.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of obesity and diabetes, particularly in diverse populations.

How similar studies have gone: Other studies have shown success in exploring the links between obesity, diabetes, and ethnicity, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants will be healthy individuals between the ages of 18-75 years. These cutoffs are designed to allow inclusion of postmenopausal women, and younger/more active patients who are increasingly undergoing bariatric surgery.
* Patients with either diabetes type 2 or the metabolic syndrome will be included in the cohort.

Exclusion Criteria:

* Participants with chronic kidney disease (\> stage 4)
* Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)
* Unstable angina, New York (NY) class III or IV congestive heart failure or myocardial infarction within 3 months of entry
* Clinically significant liver disease (e.g. Cirrhosis or liver failure)
* Weight \> 450 pounds (DXA scan weight limit)
* History of organ transplant
* Treatment with chemotherapy or radiation therapy at the time of enrollment in study.
* Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oral glucocorticoids)
* Current nasal corticosteroid use (within the past month)
* Excessive alcohol or substance abuse
* Current use of anabolic steroids or testosterone for bodybuilding purposes. Testosterone use is permitted if prescribed for hypogonadism and dose stable for the past 6 months.
* Patients actively enrolled in interventional trials involving investigational agents
* Pregnant or breast-feeding women
* Appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee.
* History of abnormal clotting
* Previous bariatric surgery
* Anticoagulant use
* Methadone medication

Where it's running

  • University of California San Francisco
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Suneil Koliwad, MD,PhD — University of California, San Francisco

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.